Defective Drugs

Although there is always some risk with any medical treatment, drug developers and manufacturers have an obligation to make sure that the products they create are as safe as possible and that the people who use those products understand the possible dangers as well as the possible benefits.

If a pharmaceutical company knows or should know that the danger of a drug is greater than the benefit, then the company has a duty to remove the drug from the market.  Similarly, if the company has not given prescribers and users information about the dangers and benefits, then they must disseminate the information as quickly and clearly as possible. If the drug companies do not do these things, then they can be held responsible for the injuries and deaths caused by their dangerous or defective drug.

A dangerous drug may also be considered a defective drug if it does not provide the intended health benefits. A dangerous drug is any drug that has the potential to seriously harm its user. A drug may be considered both dangerous and defective if the sole source of its danger stems from a flaw in its manufacturing process such as an accidental chemical contamination.

Victims of dangerous and defective drugs may be entitled to compensation for medical expenses, rehabilitation costs, diminished earning capacity, lost income, and other costs and losses. However, many people who pursue this type of legal action want more than compensation for their injuries —they want to get the drug off the market so that other members of their community are not injured.

If you’ve suffered from a dangerous or defective drug, you need an experienced attorney to sort out your case and protect your rights.

Contact Siegfried & Jensen today for a free consultation. We handle drug cases throughout the entire United States. No matter where you are, we will evaluate your case for free.

No attorney can guarantee that you’ll receive compensation, but our team of pharmaceutical litigation attorneys has handled many cases on behalf of individual victims of dangerous and defective drugs. In addition, we have successfully represented a number of states in large-scale pharmaceutical litigation.